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Invadopodia: proteolytic feet of cancer cells
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Abstract: The leading cause of death in cancer patients is metastasis. Invasion is an integral part of metastasis and is carried out by
proteolytic structures called invadopodia at the cellular level. In this introductory review, we start by evaluating the definition of
invadopodia. While presenting the upstream signaling events involved, we integrate current models on invadopodia. In addition, we
discuss the significance of invadopodia in 2D and 3D and in vivo. We finally point out technical challenges and conclude with open
questions in the field.
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1. Metastasis
The leading cause of death in cancer patients is metastasis.
Metastasis defines both the process of spreading of cancer
cells from the primary tumor and the resulting secondary
tumors. The primary tumor changes its place (meta + statis)
and new tumors form at distant sites. During metastasis
of carcinoma (cancer of epithelial tissue), tumor cells
proliferate in an uncontrolled fashion, induce angiogenesis
(new blood vessel formation), degrade the underlying
basement membrane and penetrate into the connective
tissue, migrate towards blood vessels, intravasate (enter
blood vessels), survive in the blood circulation, extravasate
(exit blood vessels), and form secondary tumors in distant
organs (Figure 1A). Therefore, cancer metastasis is a
disease of altered cell adhesion, motility, and invasion.
2. Definition of invadopodia
Under physiological conditions such as bone resorption,
cells invade into tissues in a tightly regulated manner.
Normal bone osteoclasts form special cellular structures
called podosomes to degrade and thus remodel the bone
matrix. During cancer metastasis, tumor cells perform
uncontrolled invasion using cellular structures called
invadopodia (Figure 1B). The term invadopodia was first
used by Chen (1989) to describe membrane protrusions
involved in the local degradation of the extracellular
matrix. After 25 years, the field has grown to be complex
and rather complicated even in terms of definitions. There
are 3 major structures in cells, each of which can be defined
* Correspondence: devrimpesen@iyte.edu.tr
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in terms of their molecular components and the functions
they carry out. These are focal adhesions, podosomes, and
invadopodia. They do have similarities, but they are also
distinct from one another. In attempts to clear up some of
the confusion, podosomes and invadopodia have also been
collectively called invadosomes. Although focal adhesions
do share common protein markers with podosomes, they
were thought to be more distinct from podosomes and
invadopodia; however, recently proteolytic activity has
also been observed for these structures, further blurring
the borders between the definitions of these structures
(McNiven, 2013). Available data raise the question of
whether focal adhesions, podosomes, and invadopodia
share a common precursor. A conservative comparison of
focal adhesions, podosomes, and invadopodia is presented
in the Table. Please note that this table is compiled
conservatively to include the data most commonly
agreed upon in the literature. There are also several
reviews and milestone papers describing in detail various
aspects summarized here (Ayala et al., 2006; Gimona and
Buccione, 2006; Linder, 2007; Gimona et al., 2008; Caldieri
et al., 2009; Linder, 2009; Yilmaz and Christofori, 2009;
Linder et al., 2011a, 2011b; Murphy and Courtneidge,
2011; Oser et al., 2011; Yamaguchi, 2012). In particular,
there are comprehensive reviews on the signaling
mechanisms involved (Stylli et al., 2008; Destaing et al.,
2011; Hoshino et al., 2013). In this review, we will focus
on invadopodia, integrate current models, and point out
technical challenges and open questions in the field.
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Figure 1. Metastasis and invadopodia. A. Metastasis comprises (i) uncontrolled proliferation, (ii)
angiogenesis, (iii) invasion, (iv) intravasation, (v) extravasation, and (vi) secondary tumor formation.
Invasion involves matrix degradation carried out by invadopodia. B. Invadopodiaform and mature at
multiple stages: (i) initiation, (ii) stabilization, and (iii) maturation (see also Figure 3). Initiation involves
recruitment of actin and cortactin, MT1-MMP recruitment leads to stabilization. Maturation stage involves
matrix degradation. When cells are on a thick matrix, invadopodia appear as membrane protrusions
penetrating into the extracellular matrix. C. Electron micrograph of an MDA-MB-231 cell cultured on
gelatin. The ultrastructure of invadopodia (arrows) is shown. Reprinted by permission from Macmillan
Publishers Ltd: Oncogene (Bowden et al., 1999) copyright 1999.

Invadopodia are relatively dynamic, actin rich,
proteolytic cellular structures formed by invasive cancer
cells (Bowden et al., 2006; Buccione et al., 2009; Linder,
2009; Linder and Aepfelbacher, 2003) (Figure 2).
Invadopodia can be from a few hundred nanometers to
several microns wide and can be up to 8 micrometers if
the underlying matrix is thick enough (Baldassarre et al.,
2003). Invadopodia also form on stiff substrates such as
glass and thus they can be studied with high resolution
imaging (DesMarais et al., 2009). The molecular markers
for invadopodia include actin and its associated proteins
cortactin, Arp2/3, N-WASP, Nck1, and cofilin as well as
matrix metalloproteinase MT1-MMP (Artym et al., 2006;
Stylli et al., 2008; Oser et al., 2009, 2011). In addition,
actin filaments, microtubules, and intermediate filaments
cooperate during invadopodia elongation (Schoumacher
et al., 2010). In melanoma cells, invadopodia contain
α3β1 integrin at the core and α5β1 integrin at the
periphery (Mueller et al., 1999). Integrins at invadopodia
may function to signal and to focus degradation of the
extracellular matrix (ECM) (Buccione et al., 2009; Mueller

et al., 1999). However, it is unclear if invadopodia have
an adhesive function as they lack vinculin (Gimona et al.,
2008; Linder, 2009). That is, whether invadopodia require
local adhesion at the sites of formation is unknown.
Preliminary results from our lab using nano-patterned
surfaces suggest that invadopodia do not require local
adhesion (unpublished data). Experiments using nanoand micro-patterned substrates can present valuable
approaches to answer such questions and other aspects
of invadopodia/podosome research such as dynamics of
mechanical properties (Labernadie et al., 2010).
In images of cells forming invadopodia, the Golgi
complex appears to be polarized and juxtaposed to the
site of invadopodia, suggesting a link between proteolytic
activity and membrane transport (Baldassarre et al.,
2003; Buccione et al., 2009; Caldieri and Buccione,
2010). However, if and how the spatial positioning of
invadopodia is controlled is not known. In addition, the
position and orientation of the Golgi can be modulated
by micrometer scale surface patterns (Thery et al., 2006).
Therefore, if invadopodia are positionally linked to the
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Table. Comparison of focal adhesions, podosomes, and invadopodia.
Focal adhesions

Podosomes

Invadopodia

virtually all cells

osteoclasts, macrophages,
endothelial cells,
smooth muscle cells

cancer cells

matrix degradation

matrix degradation

distributed

leading edge and proximal to Golgi

Composition

Actin
Vinculin
Talin
Paxillin
Focal adhesion kinase
Integrin

Actin
Vinculin
WASP
Grb2
MT1-MMP

Actin
Arp2/3
Cortactin
N-WASP
Nck1
Cofilin
Tks5
MT1-MMP

Shape

ellipse

ring

dot

Size

<20 µm

<1 µm × 4 µm

<8 µm × 5 µm

Number per cell

<400

20–100

1–40

Stability/ Persistence

stable/several hours

highly dynamic/2–12 min

dynamic/up to 3 h

Cell type
Function
Cellular localization

adhesion,
matrix degradation?
cell periphery

Golgi, changing the position of the Golgi by culturing
cells on different micrometer scale surface patterns should
also change the localization of invadopodia. Thus micropatterned substrates present themselves as valuable tools
for the question at hand.
3. Upstream of invadopodia
Growth factors act as intercellular signaling molecules
that promote various processes such as cell growth,
proliferation, differentiation, and motility. In addition,
growth factor receptors and integrins are known to crosstalk (Moro et al., 2002; Yamada and Even-Ram, 2002; Alam
et al., 2007; Gilcrease, 2007). Growth factors can be soluble,
transmembrane, or ECM bound proteins (Ruoslahti et al.,
1992; Massague and Pandiella, 1993; Taipale and Keski-Oja,
1997). Epidermal growth factor (EGF) is 1 of the 7 ligands
of EGF receptor (EGFR also known as ErbB1), which is
in turn the most studied member of the ErbB receptor
family (Cohen, 1962; Carpenter and Cohen, 1990; Harris
et al., 2003; Singh and Harris, 2005). Furthermore, EGFR
expression correlates with poor prognosis in breast cancer
(Sainsbury et al., 1985; Lewis et al., 1990; Memon et al.,
2006). EGF is known to induce motility and invadopodia
formation in breast cancer cells (Yamaguchi et al., 2005).
However, whether EGFR is present at invadopodia and
acts directly and locally or not is not known.
In terms of signal transduction, growth factor receptor
tyrosine kinase and integrin initiated upstream events have
been shown to promote invadopodia formation through
phosphorylation of cortactin via a Src and Arg dependent
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pathway (Stylli et al., 2008; Oser et al., 2010; Destaing
et al., 2011; Mader et al., 2011; MacGrath and Koleske,
2012). b1 integrin has been shown to promote metastasis,
invadopodia maturation, and matrix degradation
through Arg (Beaty et al., 2013). Local changes in pH
induced by NHE1 are also shown to regulate cortactin
phosphorylation (Magalhaes et al., 2011). Furthermore,
small GTPases are shown to be spatiotemporally regulated
at invadopodia where RhoC is inactivated at the center of
invadopodia and is activated at its periphery so that cofilin
is active at the center and is inactive at the periphery
(Bravo-Cordero et al., 2011, 2012). Here, RhoC is shown
to act through ROCK, which phosphorylates LIMK, which
in turn phosphorylates and inactivates cofilin.
4. An integrated model of invadopodia
Over the years, valuable research has produced models that
describe invadopodia. An integrated model is presented in
Figure 3. One of the early studies classified invadopodia
formation into 4 stages: I. Invadopodia initiation, II.
Preinvadopodia, III. Mature invadopodia, and IV. Late
invadopodia. Cortactin levels are at their maximum at
stages II and III and subside afterwards, while actin levels
reach a peak at stage III. MT1-MMP reaches a maximum
at stage II and is stable thereafter, while matrix degradation
saturates at stage III (Artym et al., 2006).
Later on, a more detailed model was presented by Oser
et al. (2009), pointing out the central role of cortactin
in invadopodia. Here, cortactin was shown to regulate
cofilin and N-WASP activities and thus control the stages
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Figure 2. Immunofluorescence images of invadopodia in MDA-MB-231 breast cancer cells cultured
on fibronectin, an extracellular matrix protein. Actin, cortactin, and fibronectin were labeled using
blue-fluorescent phalloidin, cortactin specific antibodies followed by green-fluorescent secondary
antibodies, and fibronectin specific antibodies followed by red-fluorescent secondary antibodies,
respectively. Yellow arrows point to invadopodia. Cortactin and actin colocalize at invadopodia. At
mature invadopodia, the underlying matrix of fibronectin is also degraded. In the merged image,
cortactin, actin, and fibronectin are shown in green, blue, and red, respectively.

of invadopodia formation. Four stages were redefined
here: Stage I – Precursor formation: Cortactin, N-WASP,
cofilin, and Arp2/3 form a complex. Stage II – Activation
of actin polymerization: Nck1 joins the precursor complex
while phosphorylation of cortactin activates cofilin’s
severing activity, which in turn provides free barbed
ends for Arp2/3 for new actin polymerization. Stage III
– Stabilization: Cortactin is dephosphorylated, cofilin
re-joins the complex, and invadopodia precursors are
stabilized. Stage IV – ECM degradation: MT1-MMP is
recruited to invadopodia and ECM is degraded.
The model by Oser et al. was then refined in terms of
involvement of Tks5 and SHIP2, which are shown to be
required for invadopodia maturation but not initiation

(Sharma et al., 2013). The integrated model we present
here comprises 3 stages: initiation, stabilization, and
maturation. Initiation here describes a combination of the
previously described stages I and II and involves structural
complex formation and actin polymerization. Stabilization
includes MMP recruitment. At the maturation stage,
MMPs are activated and matrix degradation takes place.
To recapitulate, the first events in the signal transduction
pathways that result in invadopodia formation are
integrin and/or growth factor activation. Although
the intermediates are not entirely known, activation
of Src is the key event for invadopodia formation. Src
in turn activates Arg, which phosphorylates cortactin.
While unphosphorylated cortactin, unphosphrylated
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the maturation stage MT1-MMP is activated and matrix
degradation takes place.

Figure 3. Integrated model for the initiation, stabilization, and
maturation of invadopodia. Presented is a combination of various
models published in the literature through the years. Initiation:
Growth factor and/or integrin initiated signaling cascades result
in phosphorylation of cortactin by Arg, which in turn is activated
by Src. Phosphorylation of cortactin releases cofilin from the
invadopodial complex comprising Arp2/3, N-WASP, Nck1,
and Tks5. Release of cofilin promotes actin polymerization.
Stabilization: Cortactin is dephosphorylated and cofilin is rerecruited to the complex. NHE1 induces local decrease in pH
and MT1-MMP is recruited. Maturation: MT1-MMP is activated
and matrix degradation takes place.

cofilin, N-WASP, Tks5, Nck1, and Arp2/3 coexist in
the pre-initiation complex, after phosphorylation of
cortactin, cofilin leaves the complex and enables actin
polymerization. At the same time, NHE1, which causes a
decrease in the local pH, is recruited. During stabilization,
cofilin is dephosphorylated and binds back to cortactin,
and MT1-MMP is recruited to invadopodia. Finally, in
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5. Invadopodia in 2D and 3D and in vivo
Invadopodia are observed in both 2D and 3D cell cultures
in vitro. Most research has been carried out in 2D cell
culture, while studies in 3D conditions are increasing.
In 2D cell culture, invadopodia are found at the ventral
surface of cells. They even form on substrates such as glass
without a matrix coating. If the substrate underneath
cancer cells is degradable and thick enough, invadopodia
extend as proteolytic protrusions into the matrix. When
cancer cells are embedded in a 3D matrix, the definition
of a ventral surface dissolves and cancer cells can form
proteolytic protrusions at various points. As in 2D, how
the cellular localization of invadopodia is determined in
3D is unknown. However, invadopodia are composed of
actin, cortactin, cofilin, Tks5, and MT1-MMP in both 2D
and 3D cultures and in vivo settings (Blouw et al., 2008;
Lizarraga et al., 2009; Magalhaes et al., 2011; Gligorijevic
et al., 2012; Yu Machesky, 2012).
Invadopodia have been observed in 2D and 3D in
vitro settings. However, the in vivo and physiological
relevance has only been recently clarified. N-WASP
expression is shown to increase in invasive breast cancer
(Yu et al., 2012). Expressions levels of cortactin have been
positively correlated with aggressiveness of head and neck
squamous cell carcinoma and breast carcinoma (Buday
and Downward, 2007; Clark et al., 2009). Expression level
of Tks5 has been shown to increase in breast cancer and
glioma (Seals et al., 2005; Stylli et al., 2012). MMP expression
levels are known to be differentially regulated in various
cancers (Kessenbrock et al., 2010). Early MMP inhibitors
failed in clinical trials, and their nonproteolytic functions
are speculated to be one of the reasons. However, there
are still promising candidates such as MT1-MMP (Chen
et al., 1994; Chen, 1996; Sabeh et al., 2009). In addition,
upstream players that induce invadopodia formation such
as MenaINV, Arg, IL-6, EGFR, and faciogenital dysplasia
protein Fgd1, are known to have increased expression
levels in various cancers (Ayala et al., 2009; Clark et al.,
2009; Li et al., 2010b; Wang et al., 2004, 2007; Gil-Henn et
al., 2013). Thus both upstream regulators and structural
components of invadopodia present vital opportunities for
diagnosis and therapy.
6. Technical bottlenecks for research on invadopodia
A technical limitation for research on invadopodia has
been the limited number of assays for proteolytic activity.
Fluorescently labeled gelatin or fibronectin is commonly
used in addition to DQ-collagen, which becomes
fluorescent upon degradation. In addition, Packard et al.
(2009) have used a substrate that shows sites of degradation
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by MT1-MMP. Fluorogenic peptide substrates have also
been utilized to assay matrix degradation by MMPs (Leight
et al., 2013). The field would greatly benefit from novel
assays that allow the determination of matrix degradation,
particularly for 3D culture and in vivo settings.
Another bottleneck has been the difficulty in analyzing
invadopodia in a quantitative manner. Counting
invadopodia in a cell or in a field of view based on colabeling of actin and cortactin, for instance, requires either
brute force of manual counting or elegant image processing
approaches. An alternative approach has been to quantify
the area of matrix degraded by invadopodia rather than
counting individual structures (Li et al., 2010a). Welldesigned image processing approaches would be greatly
beneficial for research on invadopodia.
7. Conclusions and open questions
In conclusion, while our understanding of invadopodia
continues to improve despite confusion even at the
definitions level, the field requires the incorporation of new
technologies and there are many open questions waiting to
be answered, such as: Do focal adhesions, podosomes, and
invadopodia share a common precursor? Do invadopodia
have an adhesive function? How is the cellular localization
of invadopodia controlled? Is EGFR present at invadopodia
and does it act directly or indirectly? How can we better
assay the proteolytic activity of invadopodia? How can we
improve the quantitative analysis of invadopodia? How

can we better exploit upstream regulators and structural
components of invadopodia for the diagnosis and therapy
of cancer?
Glossary
Cortactin: Cortical actin binding protein. Cortactin
promotes actin polymerization.
Cofilin: An actin binding protein. Cofilin severs actin
filaments.
N-WASP: Neural Wiskott–Aldrich syndrome protein.
N-WASP promotes actin nucleation.
Tks5: Tyrosine kinase substrate 5, a scaffold protein.
Nck1: Noncatalytic region of tyrosine kinase adaptor
protein 1. Nck1 is an adaptor protein involved in signal
transduction.
MT1-MMP: MT1-MMP is a matrix metalloproteinase
also known as MMP-14.
Src: The first described proto-oncogene. A nonreceptor
tyrosine kinase.
Arg: A member of the Abelson family of nonreceptor
tyrosine kinases.
NHE1: A Na+/H+ exchanger.
RhoC: A member of the Rho family of small GTPases.
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